Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126409182 | 12640918 | 2 | F | 20160804 | 20160810 | 20160907 | EXP | US-GLAXOSMITHKLINE-US2016GSK114597 | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160907 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126409182 | 12640918 | 1 | PS | NUCALA | MEPOLIZUMAB | 1 | Intravenous (not otherwise specified) | 100 MG, CYC | 125526 | 100 | MG | POWDER FOR INJECTION | |||||||
126409182 | 12640918 | 2 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 | INHALATION POWDER | |||||||||||
126409182 | 12640918 | 3 | SS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | U | 0 | |||||||||||
126409182 | 12640918 | 4 | SS | TOPAMAX | TOPIRAMATE | 1 | U | 0 | |||||||||||
126409182 | 12640918 | 5 | SS | XOPENEX | LEVALBUTEROL HYDROCHLORIDE | 1 | 0 | ||||||||||||
126409182 | 12640918 | 6 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126409182 | 12640918 | 1 | Asthma |
126409182 | 12640918 | 6 | Systemic lupus erythematosus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126409182 | 12640918 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126409182 | 12640918 | Asthma | |
126409182 | 12640918 | Back pain | |
126409182 | 12640918 | Headache | |
126409182 | 12640918 | Ill-defined disorder | |
126409182 | 12640918 | Intentional product use issue | |
126409182 | 12640918 | Joint arthroplasty | |
126409182 | 12640918 | Joint dislocation | |
126409182 | 12640918 | Knee arthroplasty | |
126409182 | 12640918 | Limb injury | |
126409182 | 12640918 | Migraine | |
126409182 | 12640918 | Multiple allergies | |
126409182 | 12640918 | Peripheral swelling | |
126409182 | 12640918 | Product substitution issue | |
126409182 | 12640918 | Respiratory distress | |
126409182 | 12640918 | Rotator cuff repair | |
126409182 | 12640918 | Shoulder arthroplasty | |
126409182 | 12640918 | Shoulder operation | |
126409182 | 12640918 | Spinal operation | |
126409182 | 12640918 | Surgery | |
126409182 | 12640918 | Systemic lupus erythematosus | |
126409182 | 12640918 | Therapeutic response unexpected | |
126409182 | 12640918 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126409182 | 12640918 | 1 | 201603 | 0 |